Last reviewed · How we verify

NCT05794828

Erector Spinae Regional Anesthesia for Pain Control

Completed EARLY_PHASE1 Last updated 27 August 2025
What this trial tests

EARLY_PHASE1 trial testing Bupivacaine Injection in Pain Management in 15 participants. Completed in 18 February 2025.

Timeline
15 September 2023
Primary endpoint
18 February 2025
18 February 2025

Quick facts

Lead sponsorThe University of Texas Health Science Center at San Antonio
PhaseEARLY_PHASE1
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment15
Start date15 September 2023
Primary completion18 February 2025
Estimated completion18 February 2025
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

The University of Texas Health Science Center at San Antonio

Who can join

18 and older, any sex, with Pain Management. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Interventional study to use erector spinae plane block (ESPB) on diagnoses of posterior or lateral rib fractures, vertebral fractures, pancreatitis, pancreatic cancer, renal colic, and back pain for multimodal pain therapy to determine its assistance with pain relief as well as the patient's use of opiates after block completion

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Bupivacaine Injection

Trials testing the same drug.

Other recruiting trials for Pain Management

Currently open trials in the same condition.

Other The University of Texas Health Science Center at San Antonio trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05794828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing